Mikael Lindlöf

1.6k total citations
21 papers, 392 citations indexed

About

Mikael Lindlöf is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Mikael Lindlöf has authored 21 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Genetics and 7 papers in Genetics. Recurrent topics in Mikael Lindlöf's work include Muscle Physiology and Disorders (9 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Mikael Lindlöf is often cited by papers focused on Muscle Physiology and Disorders (9 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Mikael Lindlöf collaborates with scholars based in Finland, United States and Sweden. Mikael Lindlöf's co-authors include Albert de la Chapelle, H Kääriäinen, Eeva‐Marja Sankila, Perttì Aula, Antti Uutela, Anna‐Elina Lehesjoki, Helena Kääriäinen, M L Savontaus, Hannu Somer and Hannu Kalimo and has published in prestigious journals such as Blood, PEDIATRICS and Journal of the Neurological Sciences.

In The Last Decade

Mikael Lindlöf

21 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikael Lindlöf Finland 12 252 113 108 56 56 21 392
T O'Brien United Kingdom 8 382 1.5× 147 1.3× 73 0.7× 115 2.1× 30 0.5× 11 483
Hiroko Wada Japan 14 461 1.8× 109 1.0× 177 1.6× 36 0.6× 43 0.8× 27 561
Jeffrey Murray United Kingdom 7 605 2.4× 284 2.5× 141 1.3× 100 1.8× 51 0.9× 8 766
Oronzo Scarciolla Italy 10 222 0.9× 71 0.6× 123 1.1× 55 1.0× 12 0.2× 12 386
H Veenema Netherlands 13 470 1.9× 396 3.5× 114 1.1× 66 1.2× 36 0.6× 24 726
Aziza Sbiti Morocco 9 211 0.8× 133 1.2× 69 0.6× 34 0.6× 14 0.3× 19 387
Kim Maincent France 7 152 0.6× 104 0.9× 41 0.4× 23 0.4× 33 0.6× 9 297
Michel Sylvain Canada 9 514 2.0× 86 0.8× 175 1.6× 55 1.0× 69 1.2× 11 609
Karin Writzl Slovenia 12 219 0.9× 238 2.1× 55 0.5× 24 0.4× 57 1.0× 33 466
Isabella Vasta Italy 9 433 1.7× 85 0.8× 146 1.4× 22 0.4× 45 0.8× 12 598

Countries citing papers authored by Mikael Lindlöf

Since Specialization
Citations

This map shows the geographic impact of Mikael Lindlöf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael Lindlöf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael Lindlöf more than expected).

Fields of papers citing papers by Mikael Lindlöf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikael Lindlöf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael Lindlöf. The network helps show where Mikael Lindlöf may publish in the future.

Co-authorship network of co-authors of Mikael Lindlöf

This figure shows the co-authorship network connecting the top 25 collaborators of Mikael Lindlöf. A scholar is included among the top collaborators of Mikael Lindlöf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikael Lindlöf. Mikael Lindlöf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tynninen, Olli, Virinder Kaur Sarhadi, Mikael Lindlöf, et al.. (2011). The hypermethylation of the O6‐methylguanine‐DNA methyltransferase gene promoter in gliomas—correlation with array comparative genome hybridization results and IDH1 mutation. Genes Chromosomes and Cancer. 51(1). 20–29. 12 indexed citations
2.
Boström, Hans, Tuija Lundán, Morten Andersen, et al.. (2007). Nordic CML Study Group Quality and Standardization Rounds for Quantitative RT-PCR of BCR-ABL To Facilitate Reporting on the International Scale.. Blood. 110(11). 4559–4559. 1 indexed citations
3.
4.
Lehesjoki, Anna‐Elina, et al.. (1999). Carrier Testing of Children for Two X-Linked Diseases: A Retrospective Evaluation of Experience and Satisfaction of Subjects and Their Mothers. Genetic Testing. 3(4). 347–355. 16 indexed citations
5.
Järvinen, Otso, Anna‐Mari Aalto, Anna‐Elina Lehesjoki, et al.. (1999). Carrier testing of children for two X linked diseases in a family based setting: a retrospective long term psychosocial evaluation. Journal of Medical Genetics. 36(8). 615–620. 16 indexed citations
6.
Watowich, Stephanie S., Xiaoling Xie, Ursula Klingmüller, et al.. (1999). Erythropoietin Receptor Mutations Associated With Familial Erythrocytosis Cause Hypersensitivity to Erythropoietin in the Heterozygous State. Blood. 94(7). 2530–2532. 37 indexed citations
7.
Vettenranta, Kim, et al.. (1998). Combined RT-PCR and Metaphase-FISH Posttransplant Studies in Pediatric Patients with Chronic Myeloid Leukemia. Journal of Pediatric Hematology/Oncology. 20(2). 108–111. 1 indexed citations
8.
9.
Ruutu, Tapani, Païvi Peltomäki, Liisa Volin, Mikael Lindlöf, & Sakari Knuutila. (1991). Karyotype and BCR studies after bone marrow transplantation for chronic myeloid leukaemia.. PubMed. 7 Suppl 2. 20–20. 1 indexed citations
10.
Kääriäinen, H, Mikael Lindlöf, Hannu Somer, & Albert de la Chapelle. (1990). Genetic counselling in Duchenne and Becker muscular dystrophy is problematic when carrier studies give controversial results. Clinical Genetics. 37(3). 179–187. 7 indexed citations
11.
Hejtmancik, J. Fielding, G. Romeo, Mikael Lindlöf, et al.. (1989). A genetic linkage map of five marker loci in and around the Duchenne muscular dystrophy locus. Genomics. 4(1). 105–109. 17 indexed citations
12.
Mäki, Tiina, et al.. (1989). Lymphocytic β-adrenergic receptors in X-linked muscular dystrophy. Journal of the Neurological Sciences. 92(2-3). 281–290. 2 indexed citations
13.
Lindlöf, Mikael, A Kiuru, H Kääriäinen, et al.. (1989). Gene deletions in X-linked muscular dystrophy.. PubMed. 44(4). 496–503. 68 indexed citations
14.
Ikonen, Riikka, et al.. (1989). Coincident maternal meiotic nondisjunction of chromosomes X and 21 without evidence of autosomal aysnapsis. Human Genetics. 83(3). 235–238. 8 indexed citations
15.
Lindlöf, Mikael, H Kääriäinen, G.J.B. van Ommen, & Albert de la Chapelle. (1988). Microdeletions in patients with X‐linked muscular dystrophy: molecular‐clinical correlations. Clinical Genetics. 33(2). 131–139. 17 indexed citations
16.
Saviranta, Petri, Mikael Lindlöf, Hannu Kalimo, et al.. (1988). Linkage studies in a new X-linked myopathy, suggesting exclusion of DMD locus and tentative assignment to distal Xq.. PubMed. 42(1). 84–8. 18 indexed citations
17.
Lindlöf, Mikael, P. Sistonen, & Albert de la Chapelle. (1987). Linked polymorphic DNA markers in the prediction of X‐linked muscular dystrophy. Annals of Human Genetics. 51(4). 317–328. 10 indexed citations
18.
Lindlöf, Mikael, H Kääriäinen, Kay E. Davies, & Albert de la Chapelle. (1986). Carrier detection and prenatal diagnosis in X linked muscular dystrophy using restriction fragment length polymorphisms.. Journal of Medical Genetics. 23(6). 560–572. 21 indexed citations
19.
Chapelle, Albert de la, et al.. (1985). Norrie disease caused by a gene deletion allowing carrier detection and prenatal diagnosis. Clinical Genetics. 28(4). 317–320. 67 indexed citations
20.
Dorkins, Huw, Jean‐Louis Mandel, Klaus Wrogemann, et al.. (1985). Segregation analysis of a marker localised Xp21.2-Xp21.3 in Duchenne and Becker muscular dystrophy families. Human Genetics. 71(2). 103–107. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T O'Brien Breakdown of academic impact, for papers by Hiroko Wada Breakdown of academic impact, for papers by Jeffrey Murray Breakdown of academic impact, for papers by Oronzo Scarciolla Breakdown of academic impact, for papers by H Veenema Breakdown of academic impact, for papers by Aziza Sbiti Breakdown of academic impact, for papers by Kim Maincent Breakdown of academic impact, for papers by Michel Sylvain Breakdown of academic impact, for papers by Karin Writzl Breakdown of academic impact, for papers by Isabella Vasta
Rankless by CCL
2026